USpolicy

News

Poll finds Americans cutting back elsewhere to fund health

Many Americans are forced to make difficult trade-offs with living expenses and delay life events like retirement to afford health, says a new poll.

News

Multicoloured letters with AUTISM spelled in the middle

FDA approves leucovorin – but not for autism

The FDA stops short of approving leucovorin for autism, but will its clearance for ultra-rare condition CFD-FOLR1 lead to more off-label prescribing?

News

CBER chief Vinay Prasad to leave FDA once again

For the second time in less than a year, Vinay Prasad has departed from the FDA, after a string of controversial regulatory decisions.

News

FDA ramps up its pushback against compounded GLP-1s

In a move that will please Novo Nordisk and Eli Lilly, the FDA sent warnings to 30 telehealth firms, accusing them of illegally marketing GLP-1 drugs.

News

CMS extends deadline for MFN pricing pilot scheme

CMS has extended the deadline for its Medicaid drug pricing pilot, GENEROUS, to "provide interested drug manufacturers more opportunity to join."

News

US lawmakers take FDA to task over rare diseases record

Lawmakers and patient advocates in the US are concerned that the FDA's regulation of rare disease therapies has been inconsistent and overly cautious.

Poll finds Americans cutting back elsewhere to fund health

FDA approves leucovorin – but not for autism

CBER chief Vinay Prasad to leave FDA once again

FDA ramps up its pushback against compounded GLP-1s

CMS extends deadline for MFN pricing pilot scheme

US lawmakers take FDA to task over rare diseases record

Regenxbio, Solid report data with Duchenne gene therapies

Using AI-driven synthetic personas to take your insights fur...

USpolicy

Editor's Picks